Skip to content
Home/Companies/HealthTech/Candid
Candid

Candid

HealthTech·US·Active·8yr hold
Entry
2018
Hold
8yr
Status
Active

Who owns Candid?

Candid is currently owned by Blisce through Blisce Deal-by-Deal (2014 vintage), since 2018.

Hand-verified · updated 2026-04-21

Blisce
Investor
Blisce
Blisce Deal-by-Deal · 2014 · Growth

Key facts

HQUSA
SectorHealthTech
Websitewww.candidpro.com

More from Blisce Deal-by-Deal

Other portfolio companies in the same fund.

Lokki
Active
ConsumerFrance· 2019
Bird
Exited 2021
MobilityUS· 2018
to
Stadium Goods
Exited 2018
ConsumerUS· 2017
to
Wecasa
Wecasa
Active
ConsumerFrance· 2016
Harry's
Harry's
Active
ConsumerUS· 2015
Teads
Teads
Exited 2017
TMTFrance· 2015
to

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
agilon health
agilon health
Active
CD&RUS
Akrivia Health
Akrivia Health
Active
Future Planet CapitalUK
Track Candid (Exit)

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Candid (Exit)?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Candid (Exit).

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue